Resources for Patients and their Families
Request Free Guide

Mesothelioma Doctors

Robert Taylor Ripley, MD

Dr. Ripley
Houston, TX

Dr. Robert Taylor Ripley

Director, Mesothelioma Treatment Center

Lung Institute at Baylor College of Medicine

Baylor Clinic
6620 Main Street, Suite 1325
Houston, TX 77030

Need Help Contacting This Doctor?

Dr. Robert Taylor Ripley is a leading mesothelioma specialist, currently serving as the director of the Mesothelioma Treatment Center at Baylor St. Luke’s Medical Center in Houston, Texas. Dr. Ripley is a nationally-recognized, experienced thoracic surgeon, with expertise in robotic thoracic surgery. He hopes to grow the robotic surgery program at Baylor Medical Center to continue improving patient outcomes.

Before becoming Director of the Mesothelioma Treatment Center, Dr. Ripley was an associate professor of surgery in the Thoracic and Oncologic Surgery Branch of the National Cancer Institute (NCI). Throughout his time at the National Cancer Institute, Dr. Ripley was very active in research for gene mutations to improve treatment methods and established the Foregut Team at the NIH Clinical Center for the management of patients with esophageal cancer. Dr. Ripley continues to be active in research in his new appointment at the Baylor Medical Center, and was recently elected to the board of the Mesothelioma Applied Research Foundation to help the advancement of mesothelioma research.

Main Specialty: Thoracic Surgery

Other Interests & Specialties: General surgery, mesothelioma, lung cancer, esophageal cancer, thymic cancer, other thoracic malignancies, infectious lung diseases, robotic thoracic surgery and robotic mediastinal surgery.

Certifications, Awards & Accolades: American Board of Surgery Certification in Surgery, American Board of Thoracic Surgery Certification in Thoracic Surgery, 2016 National Cancer Institute (NCI) Director’s Innovation Award, Board of Directors of the Mesothelioma Applied Research Foundation

Education & Experience:

Bile acid and cigarette smoke enhance the aggressive phenotype of esophageal adenocarcinoma cells by downregulation of the mitochondrial uncoupling protein-2. Oncotarget. November 2017; 8(60): 101057–101071. doi: 10.18632/oncotarget.22380

Biology is king and continues to rule. Journal of Thoracic and Cardiovascular Surgery. October 2017;154(4): 1448–1449. doi: 10.1016/j.jtcvs.2017.07.047

EGFR mutational status in lung adenocarcinoma: Staging implications or continuous evolution? Journal of Thoracic and Cardiovascular Surgery. November 2017;154(5): 1766–1767. doi: 10.1016/j.jtcvs.2017.07.053

Heated intraperitoneal chemotherapy and gastrectomy for gastric cancer in the U.S.: the time is now. Journal of Gastrointestinal Oncology. December 2017; 8(6): 1109–1113. doi: 10.21037/jgo.2017.09.01

Mesothelioma Treatment Guide

Free Mesothelioma Treatment Guide

Please fill in the form below to request our FREE Mesothelioma Treatment Guide. It will be sent to you within 24 hours.

Have you or someone you know been diagnosed with mesothelioma?

Get Access To:

Legal Rights Information Guide Free Guide Request Free Guide Free Mesothelioma Guide Free 2019 Mesothelioma Guide